Development of Improved Diagnostics for Genetic DiseaseDevelopment of Therapies for Selected Genetic Muscle DiseasesDisease AreaFundingGenesGenetic DiseaseGenetic DiseaseGenetic Neuromuscular DisordersGeneticsMedia ReleasesMusclesMuscular DystrophyNeurogenetic DiseasesNeurological DisordersNews & Events
WA scientists win Hearts and Minds
By Richard Schoonraad | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Disease Area, Funding, Genes, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Media Releases, Muscles, Muscular Dystrophy, Neurogenetic Diseases, Neurological Disorders, News & EventsFirst West Australian team to attract unique listed investment company funds One of Australia's Top 30 Corporate Philanthropists, Hearts and Minds Investments Limited (ASX: HM1) has made its first donation…
CancerCancerCancer and Cell BiologyLiverLiver CancerLiver CancerLiver DiseaseNews & Events
Hope for new drug to fight liver cancer
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Liver, Liver Cancer, Liver Cancer, Liver Disease, News & EventsPrimary liver cancer is a deadly illness and one of the fastest growing cancer types in the world. Now researchers from the Harry Perkins Institute of Medical Research have developed…
CancerCancerCancer EpigeneticsDisease AreaEpigenetics and Genomics LaboratoryLabLiverLiver CancerLiver CancerLiver DiseaseMitochondrial Medicine and BiologyNews & EventsResearch
New discovery for treatment of primary liver cancer shows promise
By Richard Schoonraad | Cancer, Cancer, Cancer Epigenetics, Disease Area, Epigenetics and Genomics Laboratory, Lab, Liver, Liver Cancer, Liver Cancer, Liver Disease, Mitochondrial Medicine and Biology, News & Events, ResearchA study using preclinical models has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer…
Advanced Clinical and Translational Cardiovascular ImagingCardiovascular DiseaseCardiovascular DiseaseCardiovascular Science and Diabetes ProgramHeartNews & EventsTreatments
AI stethoscope to help detect early signs of heart disease
By Richard Schoonraad | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, News & Events, TreatmentsNew AI stethoscope could revolutionise medicine and help detect the early signs of heart valve disease A digital stethoscope that will easily be able to detect early signs of heart…
Genetic DiseaseGenetic DiseaseGeneticsGenome Biology and GeneticsMuscular DystrophyNeurological DisordersNews & Events
Muscular dystrophy discovery increases likelihood more families will be diagnosed with muscle weakening diseases
By Richard Schoonraad | Genetic Disease, Genetic Disease, Genetics, Genome Biology and Genetics, Muscular Dystrophy, Neurological Disorders, News & EventsDiscovery changes the way geneticists analyse debilitating muscle diseases When several people in an extended family suffer from similar muscle weakening symptoms, the cause is typically a genetic disease such…
CancerCancerImmunotherapyLiver CancerMedia ReleasesMelanomaMelanoma DiscoveryMelonomaNews & EventsResearchTranslationTumours
WA melanoma research featured at global Oncology congress
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, TumoursBreakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…
Biomedical engineeringCardiovascular DiseaseCardiovascular DiseaseHeartMedia ReleasesNews & EventsVascular Engineering
3D Printed heart valves to be commercialised
By Richard Schoonraad | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, Vascular EngineeringCutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…
BacteriaCardiovascular Science and Diabetes ProgramEmergency MedicineKidney DiseaseMedia ReleasesNews & EventsSynthetic Biology and Drug DiscoveryTargeted Drug DeliveryTranslation
Antibiotics resistance solution to be commercialised
By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, TranslationBreakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…
